We have compared lipoprotein metabolism in, and susceptibility to atherosclerosis of, two strains of male Golden Syrian hamster, the Bio F 1 B hybrid and the dominant spot normal inbred (DSNI) strain. When fed a normal low-fat diet containing approximately 40 g fat and 0·3 g cholesterol/kg, triacylglycerol-rich lipoprotein (chylomicron þ VLDL) and HDL-cholesterol were significantly higher (P,0·001) in Bio F 1 B hamsters than DSNI hamsters. When this diet was supplemented with 150 g coconut oil and either 0·5 or 5·0 g cholesterol/kg, significant differences were seen in response. In particular, the high-cholesterol diet produced significantly greater increases in plasma cholesterol and triacylglycerol in the Bio F 1 B compared with the DSNI animals (P¼ 0·002 and P,0·001 for cholesterol and triacylglycerol, respectively). This was particularly dramatic in non-fasting animals, suggesting an accumulation of chylomicrons. In a second experiment, animals were fed 150 g coconut oil/kg and 5·0 g cholesterol/kg for 6 and 12 months. Again, the Bio F 1 B animals showed dramatic increases in plasma cholesterol and triacylglycerol, and this was confirmed as primarily due to a rise in chylomicron concentration. Post-heparin lipoprotein lipase activity was significantly reduced (P,0·001) in the Bio F 1 B compared with the DSNI animals at 6 months, and virtually absent at 12 months. Bio F 1 B animals were also shown to develop significantly more (P,0·001) atherosclerosis. These results indicate that, in the Bio F 1 B hybrid hamster, cholesterol feeding reduces lipoprotein lipase activity, thereby causing the accumulation of chylomicrons that may be associated with their increased susceptibility to atherosclerosis. The male Golden Syrian hamster has been used extensively in studies of lipoprotein metabolism because it is more similar in this respect to man than other rodent species. It has also proven to be a useful model in studying pharmacological (Kowala et al.
The male Golden Syrian hamster has been used extensively in studies of lipoprotein metabolism because it is more similar in this respect to man than other rodent species. It has also proven to be a useful model in studying pharmacological (Kowala et al. 1991 (Kowala et al. , 1993 Foxall et al. 1992; Otto et al. 1995; Nicolosi et al. 1998a; Pitman et al. 1998) and nutritional influences on the development of atherosclerosis (Parker et al. 1995; Kahlon et al. 1996; Nicolosi et al. 1997 Nicolosi et al. , 1998b Xu et al. 1998; Mangiapane et al. 1999) . Previous studies in our laboratory (Mangiapane et al. 1999) showed that one strain of hamster (dominant spot normal inbred, DSNI) required high levels of dietary cholesterol (30 g/kg diet) to induce aortic lesions. This is in agreement with earlier findings of Nistor et al. (1987) . However, the hybrid Bio F 1 B strain of hamster has been shown to develop aortic atherosclerosis at much lower dietary cholesterol concentrations (Kowala et al. 1991) . The biochemical and physiological basis of this response to dietary cholesterol remains to be established.
The aim of the present study was to compare the lipoprotein responses of DSNI and Bio F 1 B hamsters to dietary cholesterol. Plasma lipoprotein profiles and hepatic cholesterol concentrations of DSNI and Bio F 1 B hamsters fed normal rodent diet or the same diet but supplemented with 150 g coconut oil/kg and either 0·5 or 5·0 g cholesterol/kg were compared. In a further experiment, we investigated the effects of feeding 150 g coconut oil and 5·0 g cholesterol/kg for 6 and 12 months on lipoprotein concentrations, heparin-releasable plasma lipase activities and atherosclerosis in the two strains of hamster.
Materials and methods

Animals and diets
All procedures involving animals in these studies were subject to UK Home Office regulations Study 1. Twenty-four 12-week-old DSNI hamsters (Joint Animal Breeding Unit, University of Nottingham, Nottingham, UK) and twenty-four 12-week-old Bio F 1 B hamsters (Biobreeders, Fitchburg, MA, USA) were housed individually at the University of Nottingham. Following acclimatisation, eight hamsters of each strain, selected by stratified randomisation of body weight, were fed normal RM3 diet containing approximately 40 g fat and 0·3 g cholesterol/kg (Special Diet Supplies, Chelmsford, Essex, UK) that had been ground to a powder. A further eight animals of each strain were fed the same diet supplemented with 150 g coconut oil (ICN Biomedicals Ltd, Thame, Oxon., UK) and 0·5 g cholesterol/kg (high-fat, low-cholesterol diet; HFLC). The remaining eight animals per strain were fed RM3 diet supplemented with 150 g coconut oil and 5·0 g cholesterol/kg (high-fat, high-cholesterol diet; HFHC). After 4 weeks, four hamsters from each group were fasted overnight, while the remaining animals were allowed free access to food until killing. The next morning, animals were anaesthetised with sodium pentabarbitone (Sagatal, 1 ml/kg), and 3 -4 ml blood collected by cardiac puncture and placed into EDTA tubes. The liver was flushed with 10 ml ice-cold 0·15 M-NaCl, removed immediately, frozen in liquid N 2 and stored at 2 208C awaiting analysis.
Study 2. Sixteen 12-week-old Bio F 1 B and sixteen 12-week-old DSNI male hamsters were housed at the University of Nottingham as described earlier. Following acclimatisation, they were fed RM3 diet (Special Diet Supplies) supplemented with 150 g coconut oil and 5·0 g cholesterol/kg. Animals from each strain were allocated to two groups of eight by stratified randomisation for body weight. One group from each strain was killed at 6 months and the remaining animals after 12 months. Animals were fed ad libitum until they were killed. At killing, four animals from each group were anaesthetised and blood collected as described earlier. The remaining animals were anaesthetised and injected with 200 ml heparin (Sigma, Poole, Dorset, UK) in 0·15 M-NaCl (approximately 7500 units/kg body weight) via the vena cava. After 5 min, blood was collected from the heart by cardiac puncture and plasma separated and stored at 2 208C awaiting analysis for post-heparin lipase activity. The hearts and aortae were then removed and the aortae cut approximately 1 mm from the base of the heart. The aortae and hearts were then fixed in neutral-buffered formalin (100 ml/l) and stored at 48C awaiting further analysis.
Lipoprotein analysis
In study 1, lipoprotein fractions were separated from plasma (normally 1 ml) by sequential ultracentrifugation and corrected for recovery (typically . 85 %) as previously described (Salter et al. 1998) . VLDL, intermediate-density lipoproteins, LDL and HDL were separated within the density ranges , 1·006, 1·006-1·020, 1·020 -1·060 and . 1·060 g/ml respectively. In non-fasted animals, the , 1·006 g/ml fraction also contained chylomicrons and so has been termed the triacylglycerol (TAG)-rich lipoprotein fraction. In study 2, chylomicrons were first isolated from the plasma by spinning at 15 500 g for 20 min at 128C. The remaining lipoproteins were then separated as described earlier. Cholesterol and TAG concentration in whole plasma and lipoprotein fractions were determined using diagnostic kits from Wako (Alpha Laboratories, Eastleigh, Hants., UK).
To confirm the identity of the TAG-rich lipoproteins, the apolipoprotein (Apo) B composition was examined by Western blotting. Lipoprotein fractions were delipidated (sample -ice-cold methanol -diethyl ether (1:12:28, by vol.)) and the remaining proteins subjected to SDS -PAGE on 4 -20 % gradient gels. Separated proteins were then transferred on to nitrocellulose membrane by Western blotting. Blots were then incubated with human polyclonal antibody to ApoB (Calbiochem, Nottingham, UK) at a dilution of 1:10 000. ApoB-48 and -100 were visualised using a secondary monoclonal anti-goat antibody conjugated to horseradish (Armoracia rusticana ) peroxidase (1:5000 dilution) with enhanced chemiluminescence detection reagent (Amersham International, Amersham, Bucks., UK).
Post-heparin lipase activity
Lipoprotein lipase (LPL) and hepatic lipase activities were measured using the method of Corey & Zilversmit (1977) as modified by Groot et al. (1992) .
Samples were analysed in triplicate. Total lipase activity was measured in the presence of 0·15 M-NaCl while hepatic lipase activity was measured by inhibiting LPL with 3·55 M-NaCl. LPL was calculated as the difference between the two values. Activity was expressed as nmol fatty acid released/ml plasma per min.
Hepatic free and esterified cholesterol
Hepatic free and esterified cholesterol were separated by TLC, extracted and assayed enzymatically as described previously by Bennett et al. (1995) .
Measurement of atherosclerosis
The heart was bisected beneath the atria and the base of the heart, which had approximately 1 mm of the ascending aorta protruding, and then submerged in optimum cutting temperature compound (Bayer Diagnostics, Leverkusen, Germany) for 24 h prior to sectioning. The heart was frozen on a cryostat chuck (Bright Instrument Company Ltd, Huntingdon, Cambs., UK) and 10 mm sections of the aortic sinus were taken from where the three aortic valve leaflets first appeared (Paigen et al. 1987; Groot et al. 1996) . Sections were stained with Oil Red O for neutral lipid and counterstained with Cole's haematoxylin for nuclei and basophilic tissue.
Images of the sections were acquired using an Olympus Zoom Stereo microscope (model SZCTV; Olympus Optical Co. Ltd, Southall, Middlesex, UK) and the area of Oil Red O lipid-staining in the sections was quantified using the Optimas Imaging software (version 5.2; Media Cybernetics Inc., Silver Spring, MD, USA) as previously described (Mangiapane et al. 1999) . Ten alternate sections were examined and the average lesion area calculated.
In addition, the remaining portions of the fixed aortae were stained with Oil Red O and the stained areas from the aortic arch to the abdominal aorta were quantified as described previously (Mangiapane et al. 1999) .
Statistical analysis
All data were checked for normal and equal distribution and those variables not normally distributed were converted to log values before statistical analyses. Such results are presented graphically as the geometric mean values and standard deviations. Data for animals fed on RM3 diet alone were analysed independently (two-way ANOVA) from that for the animals on the HFLC and HFHC diets. This was because the energy and nutrient density of the basic diet was considerably less than that of the high-fat diets. The remaining data from this trial (HFLC and HFHC groups) were analysed by three-way ANOVA, using the Genstat Computer Package (Lawes Agricultural Trust, Rothamstead, Herts., UK). The three factors in this analysis were defined as strain (S), diet (D) and whether the animals were fasted or fed (F). Significant P values (, 0·05) for the effect of these factors or the interactions between them are shown in the tables. For the second trial, data was analysed by two-way ANOVA with S and length of time on the diet (T) as factors.
Results
DSNI hamsters had a significantly greater starting body weight than Bio F 1 B hamsters (145·9 (SD 12·16) v. 124·5 (SD 15·73) g respectively, P, 0·001). This weight difference increased during the course of the trial (final body weight 157·6 (SD 12·78) v. 124·3 (SD 15·78) g respectively, P, 0·001). However, no significant effects of D or D £ S interaction were observed. Table 1 shows the lipoprotein profiles of the two strains of hamsters fed the normal diet. Animals were killed either after an overnight fast or allowed constant access to food. Bio F 1 B hamsters had significantly higher plasma cholesterol concentrations than DSNI strain and this was significant in both the TAG-rich lipoprotein and HDL fractions (P, 0·001). LDL-cholesterol did not differ between the two strains; intermediate-density cholesterol, although a very minor fraction, was significantly greater in the DSNI strain (P¼ 0·001). Plasma cholesterol was greater in fed animals of both strains than those that were fasted overnight. Plasma total and TAG-rich lipoprotein-TAG did not differ significantly between the strains. Plasma total TAG was reduced on fasting in Bio F 1 B animals, but not DSNI animals; however, the interaction between strain and fasting failed to reach statistical significance ðS £ F interaction, P¼ 0·075).
Total plasma cholesterol concentrations were higher in animals fed HFHC diet for 4 weeks than in those fed the HFLC diet, with a greater increase seen in the Bio F 1 B animals (D £ S interaction, P¼ 0·002; Fig. 1 ). Fasting caused a marked decrease (58 %) in plasma cholesterol in F 1 B compared with DSNI animals ðF £ S interaction, P¼ 0·039). Fasting decreased plasma TAG in both strains, on both diets, but this was most pronounced on the HFHC diet where an 80 % decrease was seen ðD £ F interaction, P¼ 0·002). Bio F 1 B animals showed a significantly more pronounced increase in TAG in response to the HFHC diet ðS £ D interaction, P, 0·001). The lipoproteins were analysed and the results for TAG-rich lipoproteins are shown in Fig. 2 , whilst the results for the other lipoproteins are shown in Table 2 . Fig. 2 indicates that most of the differences in total plasma lipids can be accounted for by changes in the TAG-rich lipoprotein fraction. 
chol, cholesterol; TAG, triacylglycerol; TRL, triacylglycerol-rich lipoprotein; IDL, intermediate-density lipoprotein; S, strain; F, fasted or fed. * Hamsters were killed either after an overnight fast (fasted) or allowed constant access to food (fed); for details of diet and procedures, see p.342. † P values are shown for significant (P, 0·05) effects of S and F. No significant interactions were seen between the two factors.
The HFHC diet increased TAG-rich lipoprotein, TAG and cholesterol to a greater extent in Bio F 1 B animals (S £ D interaction, P, 0·001 for both lipids). While fasting had little effect on TAG-rich lipoprotein lipids in animals on the HFLC diet, both were reduced in animals fed the HFHC diet (D £ F interaction, P¼ 0·007 and P¼ 0·002 for cholesterol and TAG respectively).
Hamsters fed HFHC diet had a greater amount of cholesterol in intermediate-density lipoprotein compared with those fed HFLC diet (Table 2 ). This effect was more pronounced in Bio F 1 B animals as illustrated by a significant S £ D interaction (P, 0·001). Intermediate-density-lipoprotein cholesterol was reduced by fasting, but to a greater extent in animals fed the HFHC than in those fed HFLC diet ðD £ F interaction, P¼ 0·002). LDL was higher in fed than fasted animals (P¼ 0·013) and DSNI animals had a greater increase in LDL-cholesterol in response to the higher dietary cholesterol level (P, 0·001). HDL tended to rise in response to the high-cholesterol diet in DSNI animals, but fell in Bio F 1 B animals, causing a significant S £ D interaction for HDL-cholesterol (P¼ 0·002). The livers of DSNI animals were significantly heavier than those from Bio F 1 B animals (P, 0·001, Table 3 ). However, this was not significant when expressed as % body weight (results not shown). Livers from fed animals were heavier than those from fasted animals and the high-cholesterol diet also produced heavier livers. Hepatic free cholesterol (Table 3 ) was significantly higher in animals fed the HFHC diet (P, 0·001) and was higher in fed than fasted animals (P¼ 0·001). Interestingly, Bio F1B hamsters had a lower hepatic cholesteryl ester content than DSNI animals. Fasting did not influence hepatic cholesteryl ester, but levels increased significantly more in the DSNI than the Bio F 1 B strain fed HFHC diet (P=0·002).
In the second study, animals were fed diets containing 150 g coconut oil and 5·0 g cholesterol/kg for 6 or 12 months. 
S, strain; D diet; F, fasted or fed. * Blood was collected following an overnight fast (fasted or following free access to food (fed)); for details of diets and procedures, see p. 342. † P values are shown for significant (P, 0·05) effects of each variable on interactions between them. As with the first trial, Bio F 1 B animals were smaller than DSNI animals at equivalent ages. The diet was generally well tolerated by both strains, although the Bio F 1 B animals tended to gain more weight, and this was significant by 12 months (25·0 (SD 2·7) v. 13·5 (SD 8·3) g body-weight gain, P¼ 0·002).
The chylomicron results are shown in Fig. 3 and the results for the other lipoproteins are shown in Table 4 . Chylomicron-cholesterol and -TAG were much higher in Bio F 1 B than DSNI animals and rose more dramatically between the two time points in the Bio F 1 B animals (T £ S interaction, P¼ 0·002 and P¼ 0·001 respectively, Fig. 3 ). The identity of this fraction as chylomicrons was confirmed by Western blotting using a polyclonal antibody against human ApoB, which indicated that virtually all of the ApoB was of the ApoB-48 rather than -100 isoform (results not shown).
Similar increases in VLDL-cholesterol (P¼ 0·005) and -TAG (P¼ 0·002) were also seen with time in Bio F 1 B hamsters (Table 4) . However, this fraction contained both ApoB-38 and -100 (results not shown) and was likely to be contaminated with chylomicrons. Intermediate-density-lipoprotein cholesterol was higher in Bio F 1 B than DSNI animals but tended to decrease with time. By contrast, LDL-cholesterol did not change significantly with time and did not differ between strains. Although both strains had similar levels of HDL-cholesterol after 6 months, they tended to rise between 6 and 12 months in DSNI hamsters and fall in Bio F 1 B hamsters causing a significant S £ T interaction (P¼ 0·012).
LPL was higher in DSNI animals than Bio F 1 B (P, 0·001, Fig. 4 ) and was significantly reduced with time in both strains (P¼ 0·006). As a result, activity was negligible in the Bio F 1 B animals after 12 months of feeding. Hepatic lipase tended to increase with time in DSNI animals, but not Bio F 1 B animals ðS £ T interaction, P¼ 0·017).
Atherosclerosis was determined in both the aortic sinus and, by en face staining, throughout the length of the aorta (Fig. 5) . No significant difference could be seen in staining in the aortic sinus between the two strains at 6 months. However, by 12 months much more staining was seen in the aortic sinus of the Bio F 1 B animals ðS £ T interaction, P¼ 0·001). In the rest of the aorta, Bio F 1 B animals showed significantly more atherosclerosis at both time points (P, 0·001), with the amount of staining increasing with time (P, 0·001). Lesions were generally restricted to the inner curvature of the aortic arch. By 12 months, atherosclerosis had spread to both the thoracic and abdominal aorta in the Bio F 1 B, although this was not seen in the DSNI hamsters.
Discussion
Previous work has indicated that the Bio F 1 B hybrid hamster is more susceptible to atherosclerosis than other non-hybrid strains (Kowala et al. 1991) . The aim of the present studies was to compare the lipoprotein response of Bio F 1 B hamster to dietary saturated fat and cholesterol with that of the more atherosclerosis-resistant DSNI strain of hamster.
Initially, we compared the lipoprotein profile of the two strains fed a normal diet with no added cholesterol or fat. No dramatic differences between the two strains were seen, although TAG-rich lipoproteins and HDL-cholesterol were both found to be higher in the Bio F 1 B than the DSNI strain. HDL was the predominant cholesterol-carrying lipoprotein in both strains, which confirms our previous findings (Sessions & Salter, 1994) and those of other investigators (Trautwein et al. 1993) .
The addition of fat and cholesterol to the diet, particularly at the higher level of 5·0 g cholesterol/kg, elicited different responses in the two strains. Bio F 1 B animals responded with a marked increase in TAG-rich lipoprotein-cholesterol and -TAG, which was most pronounced in animals on the high-cholesterol diet and in the fed state. We have previously shown an increase in VLDL-cholesterol and -TAG in other strains of hamster in response to dietary cholesterol (Sessions et al. 1994; Billett et al. 2000) . However, the magnitude of the changes seen in the Bio F 1 B hamsters was considerably greater than in other strains. The response seen in the present study is also considerably greater than that found by Trautwein et al. (1993) , who compared the response to 4·0 or 8·0 g cholesterol/kg in Bio F 1 B hamsters with that of two other strains However, these workers used a purified diet containing significantly less saturated fat (50 g butter/kg) than was used in the present study.
Elevated concentrations of TAG-rich lipoprotein, particularly in the fed state, and reduced hepatic cholesteryl ester storage in the Bio F 1 B animals is consistent with a reduced activity of LPL on these lipoproteins, and hence a reduced production and clearance of cholesterol-rich remnants by the liver. To test this hypothesis, a further experiment was designed to determine the effect of the HFHC diet on post-heparin LPL activity. The present trial was also designed to compare the development of atherosclerotic lesions in the two strains over time.
After 6 months on a diet containing 150 g coconut oil and 5·0 g cholesterol/kg, Bio F 1 B hamsters had much greater plasma total cholesterol and TAG concentrations than DSNI hamsters, and this was largely due to an accumulation of chylomicrons (as identified by density and presence of ApoB-48). By 12 months, chylomicron-TAG was more than 50-fold greater in the Bio F 1 B compared with the DSNI animals. This accumulation of chylomicrons was shown to be associated in Bio F 1 B animals with much lower activity of heparin-releasable LPL, which declined almost to zero by 12 months. Thus, the massive hyperlipidaemia associated with cholesterol feeding in Bio F 1 B hamsters is associated with an accumulation of chylomicrons, and to a lesser extent VLDL, due to a reduction in LPL activity.
At the present time, we do not know why LPL responds so differently to dietary cholesterol in these two strains. Heparin releases LPL from the vascular endothelium of many tissues in the body, with adipose tissue and skeletal muscle being quantitatively the most important. In the fed state, due to the actions of insulin, LPL activity in adipose tissue would be expected to be up-regulated and thus make the greatest contribution to the released pool. However, the fact that by 12 months virtually no activity could be detected in Bio F 1 B hamsters suggested that all tissues of the body might be affected. Absence of functional LPL is one of the underlying causes of type 1 hyperlipoproteinaemia in man. Models of such hyperlipidaemia have been described in the cat (Ginziger et al. 1996) and mink (Savonen et al. 1999) . However, these are a direct result of mutations within the gene resulting in a failure to produce functional LPL. The apparent deficiency of LPL activity in the Bio F 1 B animals was dependent on feeding dietary cholesterol. It is possible that cholesterol may exert direct effects on LPL gene expression. Sterol regulatory element binding proteins (Kim & Spiegelman, 1996; Shimano et al. 1996 Shimano et al. , 1997 Yang & Deeb, 1998) may regulate the transcription of the LPL gene. It has been shown that depletion of cholesterol, or over-expression of sterol regulatory element binding proteins 1 or 2 induces LPL gene expression in 3T3-L1 adipocytes (Schoonjans et al. 2000) . It is interesting to speculate that polymorphisms in the sterol response element of the LPL promoter may influence the response of the two strains to dietary cholesterol. However, at present, the molecular basis of this strain-specific response to dietary cholesterol remains to be established.
It is also not clear whether this phenotype is restricted to the Bio F 1 B hybrid or may be associated with one of the parent strains. The Bio F 1 B hybrid is derived from two highly inbred strains, namely Bio 87.20 female and Bio 1.5 male. Little is known about lipid metabolism in either of the parent strains, although there are some reports of altered cholesterol metabolism in the Bio 87.20 strain (Schaffer et al. 1981; Singhal et al. 1983 ). We are not aware, however, of any reports of the effect of cholesterol feeding on plasma TAG concentrations in the parent strains. It is understood that the Bio F 1 B hybrid was originally favoured due to its relative longevity and general robustness (C. VanDongen, personal communication) prior to the discovery of an increased susceptibility to atherosclerosis (Kowala et al. 1991) . Further investigation of the parental strains should provide useful information as to the genetic basis of the increased susceptibility to hyperlipidaemia.
In general, we confirm that Bio F 1 B animals are more susceptible to atherosclerosis than DSNI animals. While at 6 months no significant difference was seen in the amount of lipid staining seen at the aortic sinus between the two strains of animal, significantly more staining was seen in the aortic arch of Bio F 1 B animals (P, 0·001). By 12 months, little change was seen in the amount of atherosclerosis in the DSNI animals, but lipid staining at the aortic sinus and throughout the rest of the aorta increased dramatically, and was 5-6-fold greater in the Bio F 1 B compared with the DSNI animals. Thus, the increased susceptibility of the Bio F 1 B hamster to atherosclerosis became increasingly apparent the longer the animals were fed an atherogenic diet.
It remains to be established which lipoproteins are responsible for this increased susceptibility to atherosclerosis. It has generally been assumed that familial LPL deficiency is not associated with increased risk of atherosclerosis in man. However, Benlian et al. (1996) reported premature atherosclerosis in four patients suffering from this condition. Mice that are heterozygous for LPL deficiency actually show a decreased susceptibility to atherosclerosis (Semenkovich et al. 1998) . Semenkovich et al. (1998) suggested that a deficiency of LPL in the vessel wall could prevent the retention of atherogenic lipoproteins. However, in the ApoE knockout mouse, over-expression of LPL appears to protect against atherosclerosis (Yaghu et al. 1999). Over-expression in these animals was found in a number of tissues including the aorta. In the cholesterol-fed Bio F 1 B hamster, a deficiency in LPL activity was associated with an increased susceptibility to atherosclerosis. This could not be attributed to changes in LDL-cholesterol, which was not significantly different between the two strains. Compared with the heterozygous LPL-deficient mice (Semenkovich et al. 1998) , plasma TAG and cholesterol levels were much greater in the Bio F 1 B hamster. Feeding cholesterol to these animals resulted in the accumulation of cholesterol-enriched chylomicrons that may be atherogenic. Furthermore, we do not know the relative activity of LPL in different tissues. Recent evidence suggests that, in mice, cholesterol feeding actually induces LPL expression in macrophages, but not in adipose tissue or muscle (Zhang et al. 2001) . This was shown to be mediated through the oxysterol liver X receptor class of transcription factors. Thus, the reduction in heparin-releasable LPL may not reflect a similar change in LPL activity within the artery wall. Further study of the cholesterol-fed Bio F 1 B hamster should yield some useful insights into the possible role of TAG-rich lipoproteins and LPL in the development of atherosclerosis.
In conclusion, we confirm the susceptibility of Bio F 1 B hamsters to atherosclerosis at relatively modest dietary cholesterol concentrations. Prolonged consumption of an atherogenic diet results in the development of lesions throughout the aorta. This increase in susceptibility to the effects of dietary cholesterol is associated with a dramatic accumulation of chylomicrons in the plasma as a result of reduced LPL activity. The mechanisms underlying this strain difference remain to be established.
